Revenue (Tables)

3 Months Ended

Dec. 31, 2021

Revenue From Contract With Customer [Abstract]

Summary of Revenues Disaggregated by Product Classification and Reportable Segment

The following table presents the Company’s revenues disaggregated by product classification and by reportable segment.

	Three Months Ended December 31,
(In thousands)	2021		2020
Medical Device
Product sales	$	6,788	$	4,561
Royalties		6,886		7,909
License fees		1,213		1,425
Research, development and other		2,021		2,301
Medical Device Revenue		16,908		16,196
In Vitro Diagnostics
Product sales		5,556		5,541
Research, development and other		539		560
In Vitro Diagnostics Revenue		6,095		6,101
Total Revenue	$	23,003	$	22,297